Raphael Viscidi
Raphael Viscidi
Professor of Pediatrics, Johns Hopkins University
Verified email at
Cited by
Cited by
Case–control study of human papillomavirus and oropharyngeal cancer
G D'Souza, AR Kreimer, R Viscidi, M Pawlita, C Fakhry, WM Koch, ...
New England Journal of Medicine 356 (19), 1944-1956, 2007
Case-control study of human papillomavirus and oropharyngeal cancer
R Viscidi, M Pawlita, WM Koch, WH Westra, ML Gillison
The New England Journal of Medicine 356 (19), 1944, 2007
Distinct risk factor profiles for human papillomavirus type 16–positive and human papillomavirus type 16–negative head and neck cancers
ML Gillison, G D'Souza, W Westra, E Sugar, W Xiao, S Begum, R Viscidi
Journal of the National Cancer Institute 100 (6), 407-420, 2008
Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study
R Herrero, X Castellsagué, M Pawlita, J Lissowska, F Kee, P Balaram, ...
Journal of the National Cancer Institute 95 (23), 1772-1783, 2003
Isolation rates and toxigenic potential of Clostridium difficile isolates from various patient populations
R Viscidi, S Willey, JG Bartlett
Gastroenterology 81 (1), 5-9, 1981
Association between the vaginal microbiota, menopause status and signs of vulvovaginal atrophy
RM Brotman, MD Shardell, P Gajer, D Fadrosh, K Chang, M Silver, ...
Menopause (New York, NY) 21 (5), 450, 2014
Engineering an intracellular pathway for major histocompatibility complex class II presentation of antigens
TC Wu, FG Guarnieri, KF Staveley-O'Carroll, RP Viscidi, HI Levitsky, ...
Proceedings of the National Academy of Sciences 92 (25), 11671-11675, 1995
Inhibition of antigen-induced lymphocyte proliferation by Tat protein from HIV-1
RP Viscidi, K Mayur, HM Lederman, AD Frankel
Science 246 (4937), 1606-1608, 1989
Clinician's guide to human papillomavirus immunology: knowns and unknowns
MH Einstein, JT Schiller, RP Viscidi, HD Strickler, P Coursaget, T Tan, ...
The Lancet infectious diseases 9 (6), 347-356, 2009
Epidemiologic and microbiologic correlates of Chlamydia trachomatis infection in sexual partnerships
TC Quinn, C Gaydos, M Shepherd, L Bobo, EW Hook, R Viscidi, ...
Jama 276 (21), 1737-1742, 1996
Seroreactivity to human papillomavirus (HPV) types 16, 18, or 31 and risk of subsequent HPV infection: results from a population-based study in Costa Rica
RP Viscidi, M Schiffman, A Hildesheim, R Herrero, PE Castle, MC Bratti, ...
Cancer Epidemiology and Prevention Biomarkers 13 (2), 324-327, 2004
Human papillomavirus infection and oral cancer: a case-control study in Montreal, Canada
J Pintos, MJ Black, N Sadeghi, P Ghadirian, AG Zeitouni, RP Viscidi, ...
Oral oncology 44 (3), 242-250, 2008
Generation and characterization of DNA vaccines targeting the nucleocapsid protein of severe acute respiratory syndrome coronavirus
TW Kim, JH Lee, CF Hung, S Peng, R Roden, MC Wang, R Viscidi, ...
Journal of virology 78 (9), 4638-4645, 2004
Coronavirus immunoreactivity in individuals with a recent onset of psychotic symptoms
EG Severance, FB Dickerson, RP Viscidi, I Bossis, CR Stallings, ...
Schizophrenia bulletin 37 (1), 101-107, 2011
Asymptomatic reactivation of JC virus in patients treated with natalizumab
Y Chen, E Bord, T Tompkins, J Miller, CS Tan, RP Kinkel, MC Stein, ...
New England Journal of Medicine 361 (11), 1067-1074, 2009
A phase I trial of a human papillomavirus DNA vaccine for HPV16+ cervical intraepithelial neoplasia 2/3
CL Trimble, S Peng, F Kos, P Gravitt, R Viscidi, E Sugar, D Pardoll, TC Wu
Clinical Cancer Research 15 (1), 361-367, 2009
Age-specific seroprevalence of Merkel cell polyomavirus, BK virus, and JC virus
RP Viscidi, DE Rollison, VK Sondak, B Silver, JL Messina, AR Giuliano, ...
Clin. Vaccine Immunol. 18 (10), 1737-1743, 2011
Antibodies to HPV-16 E6 and E7 proteins as markers for HPV-16-associated invasive cervical cancer
M Moller, RP Viscidi, Y Sun, E Guerrero, PM Hill, F Shah, FX Bosch, ...
Virology 187 (2), 508-514, 1992
Population genetics of microbial pathogens estimated from multilocus sequence typing (MLST) data
M Pérez-Losada, EB Browne, A Madsen, T Wirth, RP Viscidi, KA Crandall
Infection, Genetics and Evolution 6 (2), 97-112, 2006
Seroprevalence of human papillomavirus-16,-18,-31, and-45 in a population-based cohort of 10 000 women in Costa Rica
SS Wang, M Schiffman, TS Shields, R Herrero, A Hildesheim, MC Bratti, ...
British journal of cancer 89 (7), 1248-1254, 2003
The system can't perform the operation now. Try again later.
Articles 1–20